Académique Documents
Professionnel Documents
Culture Documents
DOI 10.1007/s00253-006-0578-0
Received: 8 May 2006 / Revised: 26 June 2006 / Accepted: 10 July 2006 / Published online: 17 October 2006
# Springer-Verlag 2006
Introduction
Free radicals are highly reactive, short-lived, toxic molecules that have one or more unpaired electrons and can
damage DNA, proteins, lipids, and carbohydrates (Baskar
et al. 2004) within the tissue. The main cause of mortality
and morbidity in the western world is atherosclerosis, the
accumulation of oxysterol, cholesterol, and peroxide lipids
in arteries, generated by free radicals which lead to heart
attack. Hence, there has been an increased interest in the
application of antioxidants to medical treatment as information are constantly gathered, linking the development of
human diseases to oxidative stress (Vaya and Aviram 2001)
that leads to the generation of free radicals. The effect of
dietary antioxidants on the development of human atherosclerosis is also controversial and a number of contradictory
examples have been published. Most of the research on the
role of antioxidants in cardiovascular diseases has focused
on testing pure compound to prevent lipid peroxidation by
examining its ability to scavenge free radicals. However,
antioxidant contribution in vivo goes far beyond scavenging
free radicals. Moreover, single antioxidants are usually not
present alone in biological systems but act in combination
with other antioxidants. Hence the protective effect of a diet
is not equivalent to the protective effect of antioxidants in it
(Helliwell 2000).
Korantzopoulos (2004) reported that antioxidant effects
of statins might extend beyond atherosclerosis and potential
benefit for atrial fibrillation and heart failure. Red yeast rice
obtained by fermentation with M. purpureus produces
various secondary metabolites and is a common food item
found in China. It was used for many centuries to enhance
the colour and flavour of food, as well as a traditional
medicine for digestive and vascular functions (Ma et al.
2000). The monacolins from Monascus sp (Heber et al.
1198
1199
Fig. 1 Purification of
dihydromonacolin-MV from
M. purpureus by silica gel
column chromatography using
different solvent systems
Mass spectrometry
Lipid peroxidation inhibitory activity of dihydromonacolinMV was measured according to the method of Kulkarni et
al. (2004). Egg lecithin (3 mg mlj1 in phosphate buffer,
pH 7.4) was sonicated (Hielscher GmbH UP 50H ultrachallprozessor sonicator) for 30 min to obtain small
membrane liposome vesicles. Different concentrations of
dihydromonacolin-MV (515 g mlj1) were added to
1200
Yield (%)
Hexane
Chloroform
Ethyl acetate
Acetone
Methanol
BHA
5.630.18
3.490.24
1.210.08
1.080.09
13.070.17
13.910.33
9.261.22
19.170.20
8.670.63
59.781.66
79.910.51
Results
The sequential solvent extraction followed by repeated
silica gel column chromatography of M. purpureus
powder yielded a potential antioxidant compound. Higher
Fig. 2 HPLC elution profile of
dihydromonacolin-MV
purified from M. purpureus
1201
11-CH3
12-CH3
23-CH3, 24-CH3
20-CH3
13-CH2
22-CH
6-CH
14-CH2
4-CH2
5-CH2
10-CH
18-CH2
1C
2-CH
9-CH
16-CH2
17-CH
3-CH
15-CH
8-CH
7-CH
19-CO
21-CO
a
Chemical shift
Carbon-13
Protona
18.9
19.1
22.5
23.1
27.2
29.8
30.9
35.2
36.3
36.1
42.3
40.9
42.3
43.4
44.3
46.9
65.8
65.4
70.9
117.2
121.5
171.5
176.1
1.21 (s)
1.25 (s)
1.18 (d, 6.5 Hz), 1.15 (d, 6.5 Hz)
1.27 (d, J=6.3 Hz)
1.26, 1.43 (m)
1.3 (J=3.3 Hz, septet)
1.33 (m)
1.92 (m)
1.89 (m)
1.85 (m)
2.68 (m)
2.65, 2.51 (dd, J=3.8, 6.1 Hz)
2.57 (t1)
2.55 (m)
2.52, 2.68 (m)
4.35 (m)
4.63 (m)
3.8 (m)
6.75 (d, 10.5)
6.55 (m, 10.5)
Discussion
M. purpureus and A. terreus that produce secondary
metabolite known as monacolins and dihydromevinolin
(Ma et al. 2000; Albers-Schonberg et al. 1981) are known
to inhibit the enzyme HMG-CoA reductase. The statins play
important role in atherosclerosis as antioxidant by preventing
the oxidation of low-density lipoprotein during oxidative
stress (Rosenson 2004). However, there is no evidence for
the antioxidant or radical scavenging activity of monacolins
from M. purpureus. Thus, the report on characterization of
dihydromonacolin-MV isolated from M. purpureus for free
radical scavenging appears to new literature (Fig. 3).
Dihydromonacolin-MV strongly scavenged DPPH by
donating electrons to free radicals. Free radicals are highly
reactive, toxic molecules due to the presence of one or more
impaired electrons. Within tissue they damage DNA,
proteins, lipids and carbohydrates (Baskar et al. 2004).
The reactivity of didhydromonacolin-MV by donating its
electrons to the free radicals and its natural occurence in the
fungus suggested its use as antioxidant.
The results showed that dihydromonacolin-MV chelating
metal ions and inhibiting oxidation of lipids by breaking the
chain reaction due to Fe+3. Atherosclerosis is characterized
by the accumulation of cholesterol, lipid peroxides and
oxysterols in the arterial wall and it is the main cause of
heart attack and stroke (Vaya and Aviram 2001). Dual
activity of dihydromonacolin-MV to inhibit lipid peroxidation and scavenge free radical showed this statin characterized from M. purpureus for application to prevent
atherosclerosis.
Methanol extract
DihydromonacolinMV
BHA
Lipid
peroxidation
inhibition
activity
Super oxide
radical
scavenging
activity
100.78T2.66
20T1
36.16T1.32
5.71T0.38
163.97T2.68
15.21T0.78
32.41T1.49
264T1.6
1202
Acknowledgement Mohan A. Dhale acknowledge the Council of
Scientific and Industrial Research (CSIR), New Delhi, for providing
Research Fellowship.
References
Albers-Schonberg G, Joshua H, Lopez MB, Hensens OD, Springer JP,
Chen J, Ostrove S, Hoffaman CH, Alberts AW, Patchett AA
(1981) Dihydromevinolin, a potent hypocholesterolemic metabolite produced by Aspergillus terreus. J Antibiot (Tokyo) 34:507
512
Baskar AA, Manoharan S, Manivasagam T, Subramanian P (2004)
Temporal patterns of lipid peroxidation product formation and
antioxidants activity in oral cancer patients. Cell Mol Biol 9:665
673
Blois MS (1958) Antioxidant determinations by the use of a stable
free radical. Nature 181:11991200
Gotto AM (2003) Antioxidants, statins, and atherosclerosis. J Am Coll
Cardiol 41:12051210
Heber D, Yip I, Ashley JM, Elashoff DA, Elashoff RM, Go VLW
(1999) Cholestero-lowering effects of proprietary Chinese red
yeast rice dietary supplement. Am J Clin Nutr 69:231236
Helliwell B (2000) The antioxidant paradox. Lancet 355:11791180
Korantzopoulos P (2004) Letter to the editor. The antioxidant
effects of statins may extend beyond atherosclerosis: potential
benefit for atrial fibrillation and heart failure. Atherosclerosis
175:187